Shock, Septic Clinical Trials

76 clinical trials for Shock, Septic across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine — RECRUITING · NA
• Early Severe Illness TrAnslational BioLogy InformaticS in Humans — RECRUITING
• Early Initiated Vasopressor Therapy in the Emergency Department — RECRUITING · PHASE3
• Management of Shock in Children With SAM or Severe Underweight and Diarrhea — RECRUITING · PHASE3
• Types of Photoplethysmographic Waves in Adult Patients with Septic Shock — RECRUITING
• Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 — RECRUITING · NA
• Pituitary Function After Recovery From Septic Shock Among ICU Survivors — RECRUITING
• Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression — RECRUITING
• Early Intravenous Hydrocortisone in Sepsis — TERMINATED · NA
• Impact of an Echographic Algorithm on Hemodynamic Optimization in the First 4 Days of Septic Shock Management — COMPLETED · NA
• Multimodal Vasopressor Strategy in Septic Shock — COMPLETED · PHASE2
• Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis — ACTIVE_NOT_RECRUITING · PHASE3
• Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator — TERMINATED
• Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock — COMPLETED · NA
• Comparison of Peripheral Perfusion Indicators and Lactate Levels — COMPLETED
• Strain Echocardiography During Septic Shock : an Observational Pilot Study — COMPLETED
• Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock — COMPLETED
• L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury — TERMINATED · PHASE3
• "Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools" — NOT_YET_RECRUITING
• Fluid Overload Quantification in Septic Shock — COMPLETED
• Sevoflurane Sedation in Patients With Septic Shock — NOT_YET_RECRUITING · PHASE2
• Vitamin C, Hydrocortisone and Thiamine for Septic Shock — TERMINATED · PHASE2
• L-carnitine as an adjunct treatment for septic shock patients with acute kidney injury: a multicentre, randomized, 2-parallel group, superiority trial — TERMINATED · PHASE3
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock — COMPLETED · PHASE2
• Significance of Disseminated Intravascular Coagulation Score in Mortality for Children With Shock — NOT_YET_RECRUITING
• Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis — COMPLETED
• Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock? — COMPLETED
• Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock — NOT_YET_RECRUITING · PHASE2
• Protocolized Reduction of Non-resuscitation Fluids vs Usual Care in Septic Shock Feasibility Trial — COMPLETED · NA
• Orange Park Out-of-Hospital Quality Improvement Study for Improving CMS Sepsis Core Measures — COMPLETED · NA
• The Value of Peripheral Arterial Resistive Index in Evaluation of Tissue Perfusion in Patients With Septic Shock — COMPLETED
• Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock — ACTIVE_NOT_RECRUITING · PHASE2
• Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock — COMPLETED · NA
• Study of Progression of Community Acquired Pneumonia in the Hospital — COMPLETED
• 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension — OTHER · PHASE4
• COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2 — TERMINATED · NA
• Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock. — OTHER · PHASE3
• Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock — COMPLETED
• Neuromuscular Electrical Stimulation and Septic Shock — SUSPENDED · NA
• Peer Support for Post Intensive Care Syndrome Self-Management — OTHER · NA
• Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction — COMPLETED
• Postoperative Respiratory Abnormalities — OTHER
• Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or After Aortic Surgery — OTHER
• Early Identification of Sepsis in Children — OTHER
• The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial — COMPLETED · PHASE2
• Fluid Responsiveness in HFNC Patients — COMPLETED
• Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study — COMPLETED · PHASE1
• Effect of Albumin Administration on Vasopressor Duration in Resolving Septic Shock — TERMINATED · PHASE1
• Thiamine Supplementation in Patients With Septic Shock — WITHDRAWN · PHASE1
• Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission — OTHER

Refine this search